SME Times is powered by   
Search News
Just in:   • Indo-Nepal trade: Let's Wait for the Dust to Settle   • India-US tariff stalemate likely to be resolved in 8-10 weeks: Chief Economic Advisor  • PM Modi-Trump phone call 'moment of bonhomie', says former senior Indian official  • India ready to take relationship with EU to next level: PM Modi to Ursula von der Leyen  • India's efforts to shape sustainable future across region lauded at East Asia Summit event 
Last updated: 26 Jul, 2017  

ayushTHMB.jpg Govt establishes Pharmacopoeia Commission

india-pharma-industry.jpg
   Top Stories
» India's contribution to global GDP growth to reach 9 pc by 2035: Govt official
» Centre to help ITIs become AI-driven training centres: FM Sitharaman
» Sensex, Nifty make strong gains amid positive cues after US Fed rate cut
» US Fed decision paves the way for RBI to go for more rate cuts: Analysts
» Piyush Goyal to embark on 2-day UAE visit today
SME Times News Bureau | 26 Jul, 2017
The Government has established Pharmacopoeia Commission for Indian Medicine and Homoeopathy under the Ministry of AYUSH, the Minister of State (Independent Charge) for AYUSH, ShripadYesso Naik informed on Tuesday.

In an written reply to a question in Rajya Sabha, he said "Prime mandate of the Pharmacopoeia Commission is to steer the work of developing quality standards of Ayurvedic, Siddha, Unani and Homoeopathic drugs and publish and revise Ayurvedic & other Pharmacopoeias, Formularies and regulatory compendia of these drugs."

Pharmacopoeia Committees and Pharmacopoeia Laboratories of Indian Medicine and Homoeopathy are in place for development of respective standards and to undertake quality analysis of Ayurvedic, Siddha, Unani and Homoeopathic medicines.
National Medicinal Plants Board is established under the aegis of Ministry of AYUSH to coordinate and support cultivation, conservation, resource augmentation and sustainable development of medicinal plants for making available quality raw materials to the AYUSH drug industry.

Financial assistance is provided for these activities through Central Sector Scheme and Centrally Sponsored Scheme of National AYUSH Mission and technical guidelines have been published and disseminated to promote scientific development, cultivation and harvesting of medicinal plants.
Government has published Pharmacopoeias & Formularies containing standards of drugs and Good Manufacturing Practices are prescribed under the provisions of Drugs & Cosmetics Act, 1940 and Rules, 1945, both of which are mandatory for the industry to comply in the manufacturing of Ayurvedic, Siddha, Unani and Homoeopathic medicines.

Ayurvedic pharmacopoeia contains monographs of 645 single drugs and 202 compound formulations; Unani Pharmacopoeia contains monographs of 298 single drugs and 150 compound formulations; Siddha pharmacopoeia contains monographs of 139 single drugs and Homeopathic Pharmacopoeia contains 1117 monographs. Similarly, Ayurvedic Formulary contains 985 standardised formulations, Unani Formulary contains 1229 standardised formulations and Siddha Formulary contains 399 standardised formulations.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹84.00
₹82.25
UK Pound
₹104.65
₹108.10
Euro
₹92.50
₹89.35
Japanese Yen ₹56.10 ₹54.40
As on 25 Jul, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter